Compounds > melatonin

melatonin and arsenic trioxide

melatonin has been researched along with arsenic trioxide in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Choe, TB; Hong, SE; Jin, HO; Kim, EK; Kim, HA; Lee, JK; Lee, YH; Noh, WC; Oh, ST; Park, IC; Seong, MK; Woo, SH; Ye, SK; Yun, SM1
Akbari, ME; Bashash, D; Bayati, S; Ghaffari, SH; Nooshinfar, E; Rezaei-Tavirani, M; Safaroghli-Azar, A1
He, X; Huang, H; Liu, W; Wang, J; Wei, Z; Yang, Z; Zhang, J; Zhang, Y1
Amirzargar, MR; Faranoush, M; Kooshari, A; Nekouian, R; Shahidi, M; Shahriyary, F; Vafajoo, M1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1

Other Studies

6 other study(ies) available for melatonin and arsenic trioxide

ArticleYear
Melatonin enhances arsenic trioxide-induced cell death via sustained upregulation of Redd1 expression in breast cancer cells.
    Molecular and cellular endocrinology, 2016, Feb-15, Volume: 422

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cell Survival; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Melatonin; Oxides; Transcription Factors; Up-Regulation

2016
Melatonin promotes ATO-induced apoptosis in MCF-7 cells: Proposing novel therapeutic potential for breast cancer.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016, Volume: 83

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Breast Neoplasms; Cell Cycle; Cell Proliferation; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; MCF-7 Cells; Melatonin; Oxides; Proto-Oncogene Proteins c-myc; Real-Time Polymerase Chain Reaction; Survivin; Telomerase; Transcription, Genetic; Tumor Suppressor Protein p53

2016
Melatonin protects against arsenic trioxide-induced liver injury by the upregulation of Nrf2 expression through the activation of PI3K/AKT pathway.
    Oncotarget, 2017, Jan-17, Volume: 8, Issue:3

    Topics: Animals; Arsenic Trioxide; Arsenicals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Gene Expression Regulation; Injections, Intraperitoneal; Liver; Male; Melatonin; NF-E2-Related Factor 2; Oxidative Stress; Oxides; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Up-Regulation

2017
Angiogenesis, coagulation, and fibrinolytic markers in acute promyelocytic leukemia (NB4): An evaluation of melatonin effects.
    Journal of pineal research, 2023, Volume: 75, Issue:3

    Topics: Arsenic Trioxide; Endothelial Cells; Humans; Leukemia, Promyelocytic, Acute; Melatonin; Tretinoin

2023
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010